Do platelet apoptosis, activation, aggregation, lipid peroxidation and platelet-leukocyte aggregate formation occur simultaneously in hyperlipidemia?

Clinical Biochemistry

Volumn 38, Issue 12, 2005, Pages 1081-1087

  Sener, Azize ^a   Ozsavci, Derya ^a   Oba, Rabia ^a   Demirel, Gulderen Yanikkaya ^b   Uras, Fikriye ^a   Yardimci, K Turay ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b Centro Laboratories   (Turkey)

Author keywords

Annexin V; Apoptosis; GpIIb IIIa; GSH; Hyperlipidemia; P selectin; Platelet activation; Platelet MDA; Platelet leukocyte aggregates

Indexed keywords

ADENOSINE DIPHOSPHATE; FIBRINOGEN; FIBRINOGEN RECEPTOR; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOCORTIN 5; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; PADGEM PROTEIN; PHOSPHATIDYLSERINE; PROTEIN ANTIBODY;

ADULT; APOPTOSIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FIBRINOGEN BLOOD LEVEL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; LEUKOCYTE AGGREGATION; LIPID PEROXIDATION; MALE; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE MEMBRANE;

ADULT; APOPTOSIS; BLOOD PLATELETS; CELL ADHESION; FEMALE; FIBRINOGEN; GLUTATHIONE; HUMANS; HYPERLIPIDEMIAS; LEUKOCYTES; LIPID PEROXIDATION; MALE; P-SELECTIN; PHOSPHATIDYLSERINES; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; REFERENCE VALUES;

EID: 29144448271     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2005.09.005     Document Type: Article

References (39)

1. A. Broijersen, A. Hamsten, M. Eriksson, B. Angelin, and P. Hjemdahl Platelet activity in in vivo in hyperlipoproteinemia-Importance of combined hyperlipidemia Thromb. Haemost. 79 2 1998 268 275
2. C.J. Knight, M. Panesar, and C. Wright Altered platelet function detected by flow cytometry Arteriosc. Thromb. Vasc. Biol. 17 1997 2044 2053
3. S.J. Shattil, M. Cunningham, and J.A. Hoxie Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry Blood 70 1 1987 307 315
4. A.G. Herman Rationale for the combination of antiaggregating drugs Thromb. Res. 92 1998 S17 S21
5. B. Chong, B. Murray, M.C. Berndt, L.C. Dunlop, T. Brighton, and C.N. Chesterman Plasma P-selectin is increased in thrombotic consumptive platelet disorders Blood 83 1994 1535 1541
6. S.L. Janes, D.J. Wilson, N. Chronos, and H.A. Goodall Evaluation of whole blood flow cytometric detection of platelet bound fibrinogen on normal subjects and patients with activated platelets Thromb. Haemost. 70 4 1993 659 666
7. J. Graff, D. Andries, and M. Elsner Platelet CD 62 expression and PDGFAB secretion in patients undergoing PTCA and treatment with abciximab Br. J. Clin. Pharmacol. 51 2001 577 582
8. E. Malle, and W. Sattler Platelets and the lipoproteins: native, modified and platelet modified lipoproteins Platelets 5 1994 70 83
9. D. Ozsavci, T. Yardimci, G.Y. Demirel, E. Demiralp, F. Uras, and E. Onder Flow cytometric assay of platelet glycoprotein receptor numbers in hypercholesterolemia Platelets 13 2002 223 229
10. P.L. Perrotta, C.L. Perrotta, and E.L. Snyder Apoptotic activity in stored human platelets Transfusion 43 2003 526 535
11. G. Tonon, X. Luo, N.J. Greco, W. Chen, Y. Shi, and G.A. Jamieson Weak platelet agonist and U46619 induce apoptosis-like events in platelets, in the absence of phosphatidylserine exposure Thromb. Res. 107 2002 345 350
12. D.C. Mergel, and G. Anderman Simultaneous determination of oxidized and reduced glutathione in human rabbit red cells Methods Find. Exp. Clin. Pharmacol. 1 1979 277 282
13. J.A. Buege, and S.D. Aust Microsomal lipid peroxidation Methods Enzymol. 53 1978 302 311
14. M.M. Bradford A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein dye binding Anal. Biochem. 72 1976 248 254
15. M.B. Schwartz, J. Hawiger, S. Timmons, and G.C. Friesinger Platelet aggregates in ischemic heart disease Thromb. Haemost. 43 1980 185 188
16. S. Omoto, S. Nomura, A. Shouzu, M. Nishikawa, S. Fukuhara, and T. Iwasaka Detection of monocyte-derived microparticles in patients with Type II diabetes mellitus Diabetology 45 2002 550 555
17. D. Ozsavci, T. Yardimci, G. YanIkkaya Demirel, F. Uras, N. Hekim, and O.N. Ulutin Apo A-I binding to platelets detected by flow cytometry Thromb. Res. 103 2001 117 122
18. A.C. Carvalho, R.W. Colman, and R.S. Lees Platelet function in hyperlipoproteinemia N. Engl. J. Med. 290 8 1972 434 438
19. T. Hayek, B. Fuhrman, L.M. Aviram, and J.G. Brook Intralipid infusion in patients with familial hypercholesterolemia. Effect of serum and plasma lipoproteins on platelet aggregation and macrophage cholesterol metabolism Atherosclerosis 81 1990 61 69
20. J. Nimpf, H. Wurm, G.M. Kostner, and T. Kenner Platelet activation in normo- and hyperlipoproteinemias Basic Res. Cardiol. 81 1986 437 453
21. C. Abrams, and S.J. Shattil Immunological detection of activated platelets in clinical disorders Thromb. Haemost. 65 5 1991 467 473
22. F.H. Man, R. Nieuwland, and A. Laarse Activated platelets in patients with severe hypertriglyceridemia: effect of triglyceride-lowering therapy Atherosclerosis 152 2000 407 414
23. A.D. Michelson Platelet activation by thrombin can be directly measured in whole blood through the use of the peptide GPRP and flow cytometry: methods and clinical applications Blood Coagul Fibrinolysis 5 1994 121 131
24. U. Klinkhardt, C.M. Kirchhmaier, and D. Westrup Differential in vitro effects of the platelet GpIIb/IIIa inhibitors abciximab or SR121566A on platelet aggregation, fibrinogen binding and platelet secretory parameters Thromb. Res. 97 2000 201 207
25. A.D. Michelson Flow cytometry: a clinical test of platelet function Blood 87 1996 4925 4936
26. J. Graff, U. Klinkhardt, and S. Harder Immunosuppressive therapy regimen and platelet activation in renal transplant patients Clin. Pharm. Ther. 72 4 2002 411 418
27. N.J. George, E.B. Pickett, and S. Saucerman Platelet surface glycoproteins. Studies on resting and captivated platelets and platelet membrane microparticles in normal subjects, and observation in patients during adult respiratory distress syndrome and cardiac surgery J. Clin. Invest. 78 1986 340 347
28. T.L. Lindahl, R. Festin, and A. Larsson Studies of fibrinogen binding to platelets by flow cytometry: an improved method for studies of platelet activation Thromb. Haemost. 68 2 1992 221 225
29. G. Van Willigen, G. Gorter, and J.W. Akkerman LDL increase the exposure of fibrinogen binding sites on platelets and secretion of dense granules Arteriosc. Thromb. 14 1 1994 41 46
30. G. Diminno, M.J. Silver, and A.M. Cerbone Increased binding of fibrinogen to platelets in diabetes. The role of prostaglandins and thrombaxane Blood 65 1 1985 156 162
31. A. Bröijersen, F. Karpe, A. Hamsten, A.H. Goodall, and P. Hjemdahl Alimentary lipemia enhances the membrane expression of platelet P-selectin without affecting other markers of platelet activation Atherosclerosis 137 1998 107 113
32. J. Graff, U. Klinkhardt, and V.B. Schini-Kert Close relationship between the platelet activation marker CD 62 and the granular release of platelet-derived growth factor J. Pharmacol. Exp. Ther. 303 3 2002 952 957
33. I. Ott, F.J. Neumann, M. Gawaz, M. Schmitt, and A. Schomig Increased neutrophil-platelet adhesion in patients with unstable angina Circulation 94 1996 1239 1246
34. U. Klinkhardt, J. Graff, and S. Harder Clopidogrel, but not abciximab, reduced platelet leukocyte conjugates and P-selectin expression in human ex vivo in vitro model Clin. Pharmacol. Ther. 71 3 2002 176 185
35. F.H. Man, R. Nieuwland, and A. Larse Activated platelets in patient severe hypertriglyceridemia: effects of triglyceride lowering therapy Atherosclerosis 152 2000 407 414
36. B.S. Massberg, G. Enders, and R. Leiderer Platelet-endothelial cell interactions during ischemia/reperfusion: the role of P-selectin Blood 92 2 1998 507 515
37. B. Olas, and B. Wachowicz Resveratrol and vitamin C as antioxidant in blood platelets Thromb. Res. 106 2002 143 148
38. T.M. Buttke, and P.A. Sandstrom Oxidative stress as a mediator of apoptosis Immunol. Today 15 1994 7 10
39. J. Zahavi, J.D. Betterige, N.A.G. Jones, D.J. Galton, and U.V. Kakkar Enhanced in vivo platelet release reaction and malondialdehyde formation in patients with hyperlipidemia Am. J. Med. 70 1981 59 64